Annie Dionne

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

Clinical and electrophysiological parameters distinguishing acute‐onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy

Annie Dionne, Michael Nicolle, Angelika F. Hahn · Muscle & Nerve · 2009 · 128 citations

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

Richard AC Hughes, Marinos C. Dalakas, Ingemar S. J. Merkies et al. · The Lancet Neurology · 2018 · 69 citations · Full text

Rheumatology, Oral Fingolimod, Ophthalmology +10

Determination of the best electrode position for recording of the diaphragm compound muscle action potential

Annie Dionne, Anthony Parkes, Beata Engler et al. · Muscle & Nerve · 2009 · 38 citations

Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches

Corey T. McMillan, Joanne Wuu, Katya Rascovsky et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2022 · 37 citations · Full text